Active, Not Recruiting
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
NCT01983241
- Conditions
- Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +14 more
- Locations
-
- Grifols Investigative Site Phoenix, Arizona, United States
- Grifols Investigative Site Gainesville, Florida, United States
- Grifols Investigative Site Leesburg, Florida, United States
- Grifols Investigative Site Miami, Florida, United States